Malaria invasion ligand RH5 and its prime candidacy in blood-stage malaria vaccine design

References

• Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 2012; 379:413-31; PMID:22305225; http://dx.doi.org/10.1016/S0140-6736(12)60034-8
   PubMed Web of Science ®Google Scholar
• Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009; 361:455-67; PMID:19641202; http://dx.doi.org/10.1056/NEJMoa0808859
   PubMed Web of Science ®Google Scholar
• Cortes A, Mellombo M, Masciantonio R, Murphy VJ, Reeder JC, Anders RF. Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1. Infect Immun 2005; 73:422-30; PMID:15618180; http://dx.doi.org/10.1128/IAI.73.1.422-430.2005
   PubMedGoogle Scholar
• Polley SD, Mwangi T, Kocken CH, Thomas AW, Dutta S, Lanar DE, Remarque E, Ross A, Williams TN, Mwambingu G, et al. Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria. Vaccine 2004; 23:718-28; PMID:15542195; http://dx.doi.org/10.1016/j.vaccine.2004.05.031
   PubMed Web of Science ®Google Scholar
• Osier FH, Fegan G, Polley SD, Murungi L, Verra F, Tetteh KK, Lowe B, Mwangi T, Bull PC, Thomas AW, et al. Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect Immun 2008; 76:2240-8; PMID:18316390; http://dx.doi.org/10.1128/IAI.01585-07
   PubMed Web of Science ®Google Scholar
• Stanisic DI, Richards JS, McCallum FJ, Michon P, King CL, Schoepflin S, Gilson PR, Murphy VJ, Anders RF, Mueller I, et al. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness. Infect Immun 2009; 77:1165-74; PMID:19139189; http://dx.doi.org/10.1128/IAI.01129-08
   PubMed Web of Science ®Google Scholar
• Moormann AM, Sumba PO, Chelimo K, Fang H, Tisch DJ, Dent AE, John CC, Long CA, Vulule J, Kazura JW. Humoral and cellular immunity to Plasmodium falciparum merozoite surface protein 1 and protection from infection with blood-stage parasites. J Infect Dis 2013; 208:149-58; PMID:23539744; http://dx.doi.org/10.1093/infdis/jit134
   PubMedGoogle Scholar
• Corran PH, O'Donnell RA, Todd J, Uthaipibull C, Holder AA, Crabb BS, Riley EM. The fine specificity, but not the invasion inhibitory activity, of 19-kgdalton merozoite surface protein 1-specific antibodies is associated with resistance to malarial parasitemia in a cross-sectional survey in The Gambia. Infect Immun 2004; 72:6185-9; PMID:15385530
   PubMedGoogle Scholar
• Thera MA, Doumbo OK, Coulibaly D, Laurens MB, Ouattara A, Kone AK, Guindo AB, Traore K, Traore I, Kouriba B, et al. A field trial to assess a blood-stage malaria vaccine. N Engl J Med 2011; 365:1004-13; PMID:21916638; http://dx.doi.org/10.1056/NEJMoa1008115
   PubMed Web of Science ®Google Scholar
• Ogutu BR, Apollo OJ, McKinney D, Okoth W, Siangla J, Dubovsky F, Tucker K, Waitumbi JN, Diggs C, Wittes J, et al. Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya. PloS one 2009; 4:e4708; PMID:19262754; http://dx.doi.org/10.1371/journal.pone.0004708
   PubMed Web of Science ®Google Scholar
• Hayton K, Gaur D, Liu A, Takahashi J, Henschen B, Singh S, Lambert L, Furuya T, Bouttenot R, Doll M, et al. Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasion. Cell Host Microbe 2008; 4:40-51; PMID:18621009; http://dx.doi.org/10.1016/j.chom.2008.06.001
   PubMed Web of Science ®Google Scholar
• Manske M, Miotto O, Campino S, Auburn S, Almagro-Garcia J, Maslen G, O'Brien J, Djimde A, Doumbo O, Zongo I, et al. Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. Nature 2012; 487:375-9; PMID:22722859; http://dx.doi.org/10.1038/nature11174
   PubMed Web of Science ®Google Scholar
• Aikawa M, Miller LH, Johnson J, Rabbege J. Erythrocyte entry by malarial parasites. A moving junction between erythrocyte and parasite. J Cell Biol 1978; 77:72-82; PMID:96121; http://dx.doi.org/10.1083/jcb.77.1.72
   PubMed Web of Science ®Google Scholar
• Dvorak JA, Miller LH, Whitehouse WC, Shiroishi T. Invasion of erythrocytes by malaria merozoites. Science 1975; 187:748-50; PMID:803712; http://dx.doi.org/10.1126/science.803712
   PubMed Web of Science ®Google Scholar
• Singh S, Alam MM, Pal-Bhowmick I, Brzostowski JA, Chitnis CE. Distinct external signals trigger sequential release of apical organelles during erythrocyte invasion by malaria parasites. PLoS Pathog 2010; 6:e1000746; PMID:20140184; http://dx.doi.org/10.1371/journal.ppat.1000746
   PubMed Web of Science ®Google Scholar
• Riglar DT, Richard D, Wilson DW, Boyle MJ, Dekiwadia C, Turnbull L, Angrisano F, Marapana DS, Rogers KL, Whitchurch CB, et al. Super-resolution dissection of coordinated events during malaria parasite invasion of the human erythrocyte. Cell Host Microbe 2011; 9:9-20; PMID:21238943; http://dx.doi.org/10.1016/j.chom.2010.12.003
   PubMed Web of Science ®Google Scholar
• Pillai AD, Addo R, Sharma P, Nguitragool W, Srinivasan P, Desai SA. Malaria parasites tolerate a broad range of ionic environments and do not require host cation remodelling. Mol Microbiol 2013; 88:20-34; PMID:23347042; http://dx.doi.org/10.1111/mmi.12159
   PubMedGoogle Scholar
• Nagamune K, Hicks LM, Fux B, Brossier F, Chini EN, Sibley LD. Abscisic acid controls calcium-dependent egress and development in Toxoplasma gondii. Nature 2008; 451:207-10; PMID:18185591; http://dx.doi.org/10.1038/nature06478
   PubMed Web of Science ®Google Scholar
• Iyer J, Gruner AC, Renia L, Snounou G, Preiser PR. Invasion of host cells by malaria parasites: a tale of two protein families. Mol Microbiol 2007; 65:231-49; PMID:17630968; http://dx.doi.org/10.1111/j.1365-2958.2007.05791.x
   PubMed Web of Science ®Google Scholar
• Duraisingh MT, Triglia T, Ralph SA, Rayner JC, Barnwell JW, McFadden GI, Cowman AF. Phenotypic variation of Plasmodium falciparum merozoite proteins directs receptor targeting for invasion of human erythrocytes. Embo J 2003; 22:1047-57; PMID:12606570; http://dx.doi.org/10.1093/emboj/cdg096
   PubMed Web of Science ®Google Scholar
• Mitchell GH, Hadley TJ, McGinniss MH, Klotz FW, Miller LH. Invasion of erythrocytes by Plasmodium falciparum malaria parasites: evidence for receptor heterogeneity and two receptors. Blood 1986; 67:1519-21; PMID:3516259;
   PubMed Web of Science ®Google Scholar
• Perkins ME, Holt EH. Erythrocyte receptor recognition varies in Plasmodium falciparum isolates. Mol Biocheml Parasitol 1988; 27:23-34; http://dx.doi.org/10.1016/0166-6851(88)90021-7
   PubMed Web of Science ®Google Scholar
• Camus D, Hadley TJ. A Plasmodium falciparum antigen that binds to host erythrocytes and merozoites. Science 1985; 230:553-6; PMID:3901257; http://dx.doi.org/10.1126/science.3901257
   PubMed Web of Science ®Google Scholar
• Maier AG, Duraisingh MT, Reeder JC, Patel SS, Kazura JW, Zimmerman PA, Cowman AF. Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populations. Nat Med 2003; 9:87-92; PMID:12469115; http://dx.doi.org/10.1038/nm807
   PubMedGoogle Scholar
• Adams JH, Blair PL, Kaneko O, Peterson DS. An expanding ebl family of Plasmodium falciparum. Trends Parasitol 2001; 17:297-9; PMID:11378038; http://dx.doi.org/10.1016/S1471-4922(01)01948-1
   PubMed Web of Science ®Google Scholar
• Gilberger TW, Thompson JK, Triglia T, Good RT, Duraisingh MT, Cowman AF. A novel erythrocyte binding antigen-175 paralogue from Plasmodium falciparum defines a new trypsin-resistant receptor on human erythrocytes. J Biol Chem 2003; 278:14480-6; PMID:12556470; http://dx.doi.org/10.1074/jbc.M211446200
   PubMed Web of Science ®Google Scholar
• Mayer DC, Mu JB, Kaneko O, Duan J, Su XZ, Miller LH. Polymorphism in the Plasmodium falciparum erythrocyte-binding ligand JESEBL/EBA-181 alters its receptor specificity. Proc Natl Acad Sci U S A 2004; 101:2518-23; PMID:14983041; http://dx.doi.org/10.1073/pnas.0307318101
   PubMedGoogle Scholar
• Peterson DS, Wellems TE. EBL-1, a putative erythrocyte binding protein of Plasmodium falciparum, maps within a favored linkage group in two genetic crosses. Mol Biochem Parasitol 2000; 105:105-13; PMID:10613703; http://dx.doi.org/10.1016/S0166-6851(99)00173-5
   PubMedGoogle Scholar
• Galinski MR, Medina CC, Ingravallo P, Barnwell JW. A reticulocyte-binding protein complex of Plasmodium vivax merozoites. Cell 1992; 69:1213-26; PMID:1617731; http://dx.doi.org/10.1016/0092-8674(92)90642-P
   PubMed Web of Science ®Google Scholar
• Khan SM, Jarra W, Preiser PR. The 235 kDa rhoptry protein of Plasmodium (yoelii) yoelii: function at the junction. Mol Biochem Parasitol 2001; 117:1-10; PMID:11551627; http://dx.doi.org/10.1016/S0166-6851(01)00333-4
   PubMedGoogle Scholar
• Rayner JC, Vargas-Serrato E, Huber CS, Galinski MR, Barnwell JW. A Plasmodium falciparum homologue of Plasmodium vivax reticulocyte binding protein (PvRBP1) defines a trypsin-resistant erythrocyte invasion pathway. J Exp Med 2001; 194:1571-81; PMID:11733572; http://dx.doi.org/10.1084/jem.194.11.1571
   PubMed Web of Science ®Google Scholar
• Triglia T, Duraisingh MT, Good RT, Cowman AF. Reticulocyte-binding protein homologue 1 is required for sialic acid-dependent invasion into human erythrocytes by Plasmodium falciparum. Mol Microbiol 2005; 55:162-74; PMID:15612925; http://dx.doi.org/10.1111/j.1365-2958.2004.04388.x
   PubMedGoogle Scholar
• Kaneko O, Mu J, Tsuboi T, Su X, Torii M. Gene structure and expression of a Plasmodium falciparum 220-kDa protein homologous to the Plasmodium vivax reticulocyte binding proteins. Mol Biochem Parasitol 2002; 121:275-8; PMID:12034462; http://dx.doi.org/10.1016/S0166-6851(02)00042-7
   PubMedGoogle Scholar
• Rodriguez M, Lustigman S, Montero E, Oksov Y, Lobo CA. PfRH5: a novel reticulocyte-binding family homolog of plasmodium falciparum that binds to the erythrocyte, and an investigation of its receptor. PloS one 2008; 3:e3300; PMID:18827878; http://dx.doi.org/10.1371/annotation/dde6c172-c9c3-43bb-8fc3-db54613d4424
   PubMed Web of Science ®Google Scholar
• Baum J, Chen L, Healer J, Lopaticki S, Boyle M, Triglia T, Ehlgen F, Ralph SA, Beeson JG, Cowman AF. Reticulocyte-binding protein homologue 5 - an essential adhesin involved in invasion of human erythrocytes by Plasmodium falciparum. Int J Parasitol 2009; 39:371-80; PMID:19000690; http://dx.doi.org/10.1016/j.ijpara.2008.10.006
   PubMed Web of Science ®Google Scholar
• Rayner JC, Galinski MR, Ingravallo P, Barnwell JW. Two Plasmodium falciparum genes express merozoite proteins that are related to Plasmodium vivax and Plasmodium yoelii adhesive proteins involved in host cell selection and invasion. Proc Natl Acad Sci U S A 2000; 97:9648-53; PMID:10920203; http://dx.doi.org/10.1073/pnas.160469097
   PubMed Web of Science ®Google Scholar
• Triglia T, Thompson J, Caruana SR, Delorenzi M, Speed T, Cowman AF. Identification of proteins from Plasmodium falciparum that are homologous to reticulocyte binding proteins in Plasmodium vivax. Infect Immun 2001; 69:1084-92; PMID:11160005; http://dx.doi.org/10.1128/IAI.69.2.1084-1092.2001
   PubMed Web of Science ®Google Scholar
• Dvorin JD, Bei AK, Coleman BI, Duraisingh MT. Functional diversification between two related Plasmodium falciparum merozoite invasion ligands is determined by changes in the cytoplasmic domain. Mol Microbiol 2010; 75:990-1006; PMID:20487292; http://dx.doi.org/10.1111/j.1365-2958.2009.07040.x
   PubMedGoogle Scholar
• Triglia T, Thompson JK, Cowman AF. An EBA175 homologue which is transcribed but not translated in erythrocytic stages of Plasmodium falciparum. Mol Biochem Parasitol 2001; 116:55-63; PMID:11463466; http://dx.doi.org/doi:10.1016/S0166-6851(01)00303-6
   PubMedGoogle Scholar
• Taylor HM, Triglia T, Thompson J, Sajid M, Fowler R, Wickham ME, Cowman AF, Holder AA. Plasmodium falciparum homologue of the genes for Plasmodium vivax and Plasmodium yoelii adhesive proteins, which is transcribed but not translated. Infect Immun 2001; 69:3635-45; PMID:11349024; http://dx.doi.org/10.1128/IAI.69.6.3635-3645.2001
   PubMedGoogle Scholar
• Sim BK, Chitnis CE, Wasniowska K, Hadley TJ, Miller LH. Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. Science 1994; 264:1941-4; PMID:8009226; http://dx.doi.org/10.1126/science.8009226
   PubMed Web of Science ®Google Scholar
• Dolan SA, Proctor JL, Alling DW, Okubo Y, Wellems TE, Miller LH. Glycophorin B as an EBA-175 independent Plasmodium falciparum receptor of human erythrocytes. Mol Biochem Parasitol 1994; 64:55-63; PMID:8078523; http://dx.doi.org/10.1016/0166-6851(94)90134-1
   PubMed Web of Science ®Google Scholar
• Mayer DC, Cofie J, Jiang L, Hartl DL, Tracy E, Kabat J, Mendoza LH, Miller LH. Glycophorin B is the erythrocyte receptor of Plasmodium falciparum erythrocyte-binding ligand, EBL-1. Proc Natl Acad Sci U S A 2009; 106:5348-52; PMID:19279206; http://dx.doi.org/10.1073/pnas.0900878106
   PubMedGoogle Scholar
• Lobo CA, Rodriguez M, Reid M, Lustigman S. Glycophorin C is the receptor for the Plasmodium falciparum erythrocyte binding ligand PfEBP-2 (baebl). Blood 2003; 101:4628-31; PMID:12576308; http://dx.doi.org/10.1182/blood-2002-10-3076
   PubMedGoogle Scholar
• Maier AG, Baum J, Smith B, Conway DJ, Cowman AF. Polymorphisms in erythrocyte binding antigens 140 and 181 affect function and binding but not receptor specificity in Plasmodium falciparum. Infect Immun 2009; 77:1689-99; PMID:19204093; http://dx.doi.org/10.1128/IAI.01331-08
   PubMedGoogle Scholar
• Lanzillotti R, Coetzer TL. The 10 kDa domain of human erythrocyte protein 4.1 binds the Plasmodium falciparum EBA-181 protein. Malar J 2006; 5:100; PMID:17087826; http://dx.doi.org/10.1186/1475-2875-5-100
   PubMedGoogle Scholar
• DeSimone TM, Jennings CV, Bei AK, Comeaux C, Coleman BI, Refour P, Triglia T, Stubbs J, Cowman AF, Duraisingh MT. Cooperativity between Plasmodium falciparum adhesive proteins for invasion into erythrocytes. Mol Microbiol 2009; 72:578-89; PMID:19400777; http://dx.doi.org/10.1111/j.1365-2958.2009.06667.x
   PubMedGoogle Scholar
• Sahar T, Reddy KS, Bharadwaj M, Pandey AK, Singh S, Chitnis CE, Gaur D. Plasmodium falciparum reticulocyte binding-like homologue protein 2 (PfRH2) is a key adhesive molecule involved in erythrocyte invasion. PloS one 2011; 6:e17102; PMID:21386888; http://dx.doi.org/10.1371/journal.pone.0017102
   PubMedGoogle Scholar
• Spadafora C, Awandare GA, Kopydlowski KM, Czege J, Moch JK, Finberg RW, Tsokos GC, Stoute JA. Complement receptor 1 is a sialic acid-independent erythrocyte receptor of Plasmodium falciparum. PLoS Pathog 2011; 6:e1000968; PMID:20585558; http://dx.doi.org/10.1371/journal.ppat.1000968
   PubMedGoogle Scholar
• Tham WH, Schmidt CQ, Hauhart RE, Guariento M, Tetteh-Quarcoo PB, Lopaticki S, Atkinson JP, Barlow PN, Cowman AF. Plasmodium falciparum uses a key functional site in complement receptor type-1 for invasion of human erythrocytes. Blood 2011; 118:1923-33; PMID:21685372; http://dx.doi.org/10.1182/blood-2011-03-341305
   PubMedGoogle Scholar
• Tham WH, Wilson DW, Lopaticki S, Schmidt CQ, Tetteh-Quarcoo PB, Barlow PN, Richard D, Corbin JE, Beeson JG, Cowman AF. Complement receptor 1 is the host erythrocyte receptor for Plasmodium falciparum PfRh4 invasion ligand. Proc Natl Acad Sci U S A 2010; 107:17327-32; PMID:20855594; http://dx.doi.org/10.1073/pnas.1008151107
   PubMed Web of Science ®Google Scholar
• Crosnier C, Bustamante LY, Bartholdson SJ, Bei AK, Theron M, Uchikawa M, Mboup S, Ndir O, Kwiatkowski DP, Duraisingh MT, et al. Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum. Nature 2011; 480:534-7; PMID:22080952; http://dx.doi.org/10.1038/nature10606
   PubMed Web of Science ®Google Scholar
• Chen L, Lopaticki S, Riglar DT, Dekiwadia C, Uboldi AD, Tham WH, O'Neill MT, Richard D, Baum J, Ralph SA, et al. An EGF-like protein forms a complex with PfRh5 and is required for invasion of human erythrocytes by Plasmodium falciparum. PLoS Pathog 2011; 7:e1002199; PMID:21909261; http://dx.doi.org/10.1371/journal.ppat.1002199
   PubMed Web of Science ®Google Scholar
• Reddy KS, Amlabu E, Pandey AK, Mitra P, Chauhan VS, Gaur D. Multiprotein complex between the GPI-anchored CyRPA with PfRH5 and PfRipr is crucial for Plasmodium falciparum erythrocyte invasion. Proc Natl Acad Sci U S A 2015; 112(4):1179-84; PMID:25583518; http://dx.doi.org/10.1073/pnas.1415466112
   PubMed Web of Science ®Google Scholar
• Gaur D, Mayer DC, Miller LH. Parasite ligand-host receptor interactions during invasion of erythrocytes by Plasmodium merozoites. Int J Parasitol 2004; 34:1413-29; PMID:15582519; http://dx.doi.org/10.1016/j.ijpara.2004.10.010
   PubMed Web of Science ®Google Scholar
• Gaur D, Storry JR, Reid ME, Barnwell JW, Miller LH. Plasmodium falciparum is able to invade erythrocytes through a trypsin-resistant pathway independent of glycophorin B. Infect Immun 2003; 71:6742-6; PMID:14638759; http://dx.doi.org/10.1128/IAI.71.12.6742-6746.2003
   PubMedGoogle Scholar
• Jiang L, Gaur D, Mu J, Zhou H, Long CA, Miller LH. Evidence for erythrocyte-binding antigen 175 as a component of a ligand-blocking blood-stage malaria vaccine. Proc Natl Acad Sci U S A 2011; 108:7553-8; PMID:21502513; http://dx.doi.org/10.1073/pnas.1104050108
   PubMed Web of Science ®Google Scholar
• Taylor HM, Grainger M, Holder AA. Variation in the expression of a Plasmodium falciparum protein family implicated in erythrocyte invasion. Infect Immun 2002; 70:5779-89; PMID:12228308; http://dx.doi.org/10.1128/IAI.70.10.5779-5789.2002
   PubMedGoogle Scholar
• Dolan SA, Miller LH, Wellems TE. Evidence for a switching mechanism in the invasion of erythrocytes by Plasmodium falciparum. J Clin Invest 1990; 86:618-24; PMID:2200806; http://dx.doi.org/10.1172/JCI114753
   PubMed Web of Science ®Google Scholar
• Gaur D, Furuya T, Mu J, Jiang LB, Su XZ, Miller LH. Upregulation of expression of the reticulocyte homology gene 4 in the Plasmodium falciparum clone Dd2 is associated with a switch in the erythrocyte invasion pathway. Mol Biochem Parasitol 2006; 145:205-15; PMID:16289357; http://dx.doi.org/10.1016/j.molbiopara.2005.10.004
   PubMedGoogle Scholar
• Stubbs J, Simpson KM, Triglia T, Plouffe D, Tonkin CJ, Duraisingh MT, Maier AG, Winzeler EA, Cowman AF. Molecular mechanism for switching of P. falciparum invasion pathways into human erythrocytes. Science 2005; 309:1384-7; PMID:16123303; http://dx.doi.org/10.1126/science.1115257
   PubMed Web of Science ®Google Scholar
• Kooij TW, Carlton JM, Bidwell SL, Hall N, Ramesar J, Janse CJ, Waters AP. A Plasmodium whole-genome synteny map: indels and synteny breakpoints as foci for species-specific genes. PLoS Pathog 2005; 1:e44; PMID:16389297; http://dx.doi.org/10.1371/journal.ppat.0010044
   PubMedGoogle Scholar
• Douglas AD, Williams AR, Knuepfer E, Illingworth JJ, Furze JM, Crosnier C, Choudhary P, Bustamante LY, Zakutansky SE, Awuah DK, et al. Neutralization of Plasmodium falciparum merozoites by antibodies against PfRH5. J Immunol 2014; 192:245-58; PMID:24293631; http://dx.doi.org/10.4049/jimmunol.1302045
   PubMed Web of Science ®Google Scholar
• Ord RL, Caldeira JC, Rodriguez M, Noe A, Chackerian B, Peabody DS, Gutierrez G, Lobo CA. A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein. Malar J 2014; 13:326; PMID:25135070; http://dx.doi.org/10.1186/1475-2875-13-326
   PubMed Web of Science ®Google Scholar
• Douglas AD, Williams AR, Illingworth JJ, Kamuyu G, Biswas S, Goodman AL, Wyllie DH, Crosnier C, Miura K, Wright GJ, et al. The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. Nat Commun 2011; 2:601; PMID:22186897; http://dx.doi.org/10.1038/ncomms1615
   PubMed Web of Science ®Google Scholar
• Gilson PR, Crabb BS. Morphology and kinetics of the three distinct phases of red blood cell invasion by Plasmodium falciparum merozoites. Int J Parasitol 2009; 39:91-6; PMID:18952091; http://dx.doi.org/10.1016/j.ijpara.2008.09.007
   PubMed Web of Science ®Google Scholar
• Igakura T, Kadomatsu K, Kaname T, Muramatsu H, Fan QW, Miyauchi T, Toyama Y, Kuno N, Yuasa S, Takahashi M, et al. A null mutation in basigin, an immunoglobulin superfamily member, indicates its important roles in peri-implantation development and spermatogenesis. Dev Biol 1998; 194:152-65; PMID:9501026; http://dx.doi.org/doi:10.1006/dbio.1997.8819
   PubMed Web of Science ®Google Scholar
• Fadool JM, Linser PJ. 5A11 antigen is a cell recognition molecule which is involved in neuronal-glial interactions in avian neural retina. Dev Dyn 1993; 196:252-62; PMID:8219348; http://dx.doi.org/10.1002/aja.1001960406
   PubMed Web of Science ®Google Scholar
• Wanaguru M, Liu W, Hahn BH, Rayner JC, Wright GJ. RH5-Basigin interaction plays a major role in the host tropism of Plasmodium falciparum. Proc Natl Acad Sci U S A 2013; 110:20735-40; PMID:24297912; http://dx.doi.org/10.1073/pnas.1320771110
   PubMed Web of Science ®Google Scholar
• Chen L, Xu Y, Healer J, Thompson JK, Smith BJ, Lawrence MC, Cowman AF. Crystal structure of PfRh5, an essential ligand for invasion of human erythrocytes. eLife 2014; 3:e04187; PMID:25296023; http://dx.doi.org/10.7554/eLife.04187
   PubMedGoogle Scholar
• Wright KE, Hjerrild KA, Bartlett J, Douglas AD, Jin J, Brown RE, Illingworth JJ, Ashfield R, Clemmensen SB, de Jongh WA, et al. Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies. Nature 2014; 515:427-30; PMID:25132548; http://dx.doi.org/10.1038/nature13715
   PubMed Web of Science ®Google Scholar
• Hayton K, Dumoulin P, Henschen B, Liu A, Papakrivos J, Wellems TE. Various PfRH5 polymorphisms can support Plasmodium falciparum invasion into the erythrocytes of owl monkeys and rats. Mol Biochem Parasitol 2013; 187:103-10; PMID:23305874; http://dx.doi.org/10.1016/j.molbiopara.2012.12.005
   PubMedGoogle Scholar
• Villasis E, Lopez-Perez M, Torres K, Gamboa D, Neyra V, Bendezu J, Tricoche N, Lobo C, Vinetz JM, Lustigman S. Anti-Plasmodium falciparum invasion ligand antibodies in a low malaria transmission region, Loreto, Peru. Malar J 2012; 11:361; PMID:23110555; http://dx.doi.org/10.1186/1475-2875-11-361
   PubMedGoogle Scholar
• Tran TM, Ongoiba A, Coursen J, Crosnier C, Diouf A, Huang CY, Li S, Doumbo S, Doumtabe D, Kone Y, et al. Naturally acquired antibodies specific for Plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malaria. J Infect Dis 2014; 209:789-98; PMID:24133188; http://dx.doi.org/10.1093/infdis/jit553
   PubMed Web of Science ®Google Scholar
• Patel SD, Ahouidi AD, Bei AK, Dieye TN, Mboup S, Harrison SC, Duraisingh MT. Plasmodium falciparum merozoite surface antigen, PfRH5, elicits detectable levels of invasion-inhibiting antibodies in humans. J Infect Dis 2013; 208:1679-87; PMID:23904294; http://dx.doi.org/10.1093/infdis/jit385
   PubMed Web of Science ®Google Scholar
• Chiu CY, Healer J, Thompson JK, Chen L, Kaul A, Savergave L, Raghuwanshi A, Li Wai Suen CS, Siba PM, Schofield L, et al. Association of antibodies to Plasmodium falciparum reticulocyte binding protein homolog 5 with protection from clinical malaria. Front Microbiol 2014; 5:314; PMID:25071730; http://dx.doi.org/10.3389/fmicb.2014.00314
   PubMedGoogle Scholar
• Ghim SJ, Young R, Jenson AB. Antigenicity of bovine papillomavirus type 1 (BPV-1) L1 virus-like particles compared with that of intact BPV-1 virions. J Gen Virol 1996; 77 ( Pt 2):183-8; PMID:8627221; http://dx.doi.org/10.1099/0022-1317-77-2-183
   PubMedGoogle Scholar
• Martin L, Stricher F, Misse D, Sironi F, Pugniere M, Barthe P, Prado-Gotor R, Freulon I, Magne X, Roumestand C, et al. Rational design of a CD4 mimic that inhibits HIV-1 entry and exposes cryptic neutralization epitopes. Nat Biotechnol 2003; 21:71-6; PMID:12483221; http://dx.doi.org/10.1038/nbt768
   PubMed Web of Science ®Google Scholar
• Han T, Sui J, Bennett AS, Liddington RC, Donis RO, Zhu Q, Marasco WA. Fine epitope mapping of monoclonal antibodies against hemagglutinin of a highly pathogenic H5N1 influenza virus using yeast surface display. Biochem Biophys Res Commun 2011; 409:253-9; PMID:21569761; http://dx.doi.org/10.1016/j.bbrc.2011.04.139
   PubMed Web of Science ®Google Scholar
• Mehlin C, Boni E, Buckner FS, Engel L, Feist T, Gelb MH, Haji L, Kim D, Liu C, Mueller N, et al. Heterologous expression of proteins from Plasmodium falciparum: results from 1000 genes. Mol Biochem Parasitol 2006; 148:144-60; PMID:16644028; http://dx.doi.org/10.1016/j.molbiopara.2006.03.011
   PubMed Web of Science ®Google Scholar
• Aguiar JC, LaBaer J, Blair PL, Shamailova VY, Koundinya M, Russell JA, Huang F, Mar W, Anthony RM, Witney A, et al. High-throughput generation of P. falciparum functional molecules by recombinational cloning. Genome Res 2004; 14:2076-82; PMID:15489329; http://dx.doi.org/10.1101/gr.2416604
   PubMed Web of Science ®Google Scholar
• Vedadi M, Lew J, Artz J, Amani M, Zhao Y, Dong A, Wasney GA, Gao M, Hills T, Brokx S, et al. Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms. Mol Biochem Parasitol 2007; 151:100-10; PMID:17125854; http://dx.doi.org/10.1016/j.molbiopara.2006.10.011
   PubMed Web of Science ®Google Scholar
• Birkholtz LM, Blatch G, Coetzer TL, Hoppe HC, Human E, Morris EJ, Ngcete Z, Oldfield L, Roth R, Shonhai A, et al. Heterologous expression of plasmodial proteins for structural studies and functional annotation. Malar J 2008; 7:197; PMID:18828893; http://dx.doi.org/10.1186/1475-2875-7-197
   PubMedGoogle Scholar
• Bustamante LY, Bartholdson SJ, Crosnier C, Campos MG, Wanaguru M, Nguon C, Kwiatkowski DP, Wright GJ, Rayner JC. A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants. Vaccine 2013; 31:373-9; PMID:23146673; http://dx.doi.org/10.1016/j.vaccine.2012.10.106
   PubMed Web of Science ®Google Scholar
• Ord RL, Rodriguez M, Yamasaki T, Takeo S, Tsuboi T, Lobo CA. Targeting sialic acid dependent and independent pathways of invasion in Plasmodium falciparum. PloS one 2012; 7:e30251; PMID:22253925; http://dx.doi.org/10.1371/journal.pone.0030251
   PubMedGoogle Scholar
• Reddy KS, Pandey AK, Singh H, Sahar T, Emmanuel A, Chitnis CE, Chauhan VS, Gaur D. Bacterially expressed full-length recombinant Plasmodium falciparum RH5 protein binds erythrocytes and elicits potent strain-transcending parasite-neutralizing antibodies. Infect Immun 2014; 82:152-64; PMID:24126527; http://dx.doi.org/10.1128/IAI.00970-13
   PubMed Web of Science ®Google Scholar
• Bartholdson SJ, Crosnier C, Bustamante LY, Rayner JC, Wright GJ. Identifying novel Plasmodium falciparum erythrocyte invasion receptors using systematic extracellular protein interaction screens. Cell Microbiol 2013; 15:1304-12; PMID:23617720; http://dx.doi.org/10.1111/cmi.12151
   PubMedGoogle Scholar
• Caldeira Jdo C, Medford A, Kines RC, Lino CA, Schiller JT, Chackerian B, Peabody DS. Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7. Vaccine 2010; 28:4384-93; PMID:20434554; http://dx.doi.org/10.1016/j.vaccine.2010.04.049
   PubMed Web of Science ®Google Scholar
• Chackerian B, Caldeira Jdo C, Peabody J, Peabody DS. Peptide epitope identification by affinity selection on bacteriophage MS2 virus-like particles. J Mol Biol 2011; 409:225-37; PMID:21501621; http://dx.doi.org/10.1016/j.jmb.2011.03.072
   PubMedGoogle Scholar
• Peabody DS, Manifold-Wheeler B, Medford A, Jordan SK, do Carmo Caldeira J, Chackerian B. Immunogenic display of diverse peptides on virus-like particles of RNA phage MS2. J Mol Biol 2008; 380:252-63; PMID:18508079; http://dx.doi.org/10.1016/j.jmb.2008.04.049
   PubMed Web of Science ®Google Scholar
• Peabody, DS. Subunit fusion confers tolerance to peptide insertions in a virus coat protein. Arch Biochem Biophys 1997; 347:85-92; PMID:9344468; http://dx.doi.org/10.1006/abbi.1997.0312
   PubMedGoogle Scholar
• Hillman RJ, Giuliano AR, Palefsky JM, Goldstone S, Moreira ED, Jr., Vardas E, Aranda C, Jessen H, Ferris DG, Coutlee F, et al. Immunogenicity of the quadrivalent human papillomavirus (type 6/11/16/18) vaccine in males 16 to 26 years old. Clin Vaccine Immunol 2012; 19:261-7; PMID:22155768; http://dx.doi.org/10.1128/CVI.05208-11
   PubMed Web of Science ®Google Scholar
• Lopez-Macias C. Virus-like particle (VLP)-based vaccines for pandemic influenza: performance of a VLP vaccine during the 2009 influenza pandemic. Hum Vaccin Immunother 2012; 8:411-4; PMID:22330956; http://dx.doi.org/10.4161/hv.18757
   PubMed Web of Science ®Google Scholar
• Wang JW, Roden RB. Virus-like particles for the prevention of human papillomavirus-associated malignancies. Expert Rev Vaccines 2013; 12:129-41; PMID:23414405; http://dx.doi.org/10.1586/erv.12.151
   PubMed Web of Science ®Google Scholar
• Wu T, Li SW, Zhang J, Ng MH, Xia NS, Zhao Q. Hepatitis E vaccine development: a 14 year odyssey. Hum Vaccin Immunother 2012; 8:823-7; PMID:22699438; http://dx.doi.org/10.4161/hv.20042
   PubMed Web of Science ®Google Scholar
• Tumban E, Peabody J, Peabody DS, Chackerian B. A universal virus-like particle-based vaccine for human papillomavirus: longevity of protection and role of endogenous and exogenous adjuvants. Vaccine 2013; 31:4647-54; PMID:23933337; http://dx.doi.org/10.1016/j.vaccine.2013.07.052
   PubMed Web of Science ®Google Scholar
• Deans JA, Alderson T, Thomas AW, Mitchell GH, Lennox ES, Cohen S. Rat monoclonal antibodies which inhibit the in vitro multiplication of Plasmodium knowlesi. Clin Exp Immunol 1982; 49:297-309; PMID:6751636;
   PubMed Web of Science ®Google Scholar
• Spring MD, Cummings JF, Ockenhouse CF, Dutta S, Reidler R, Angov E, Bergmann-Leitner E, Stewart VA, Bittner S, Juompan L, et al. Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A. PloS one 2009; 4:e5254; PMID:19390585; http://dx.doi.org/10.1371/journal.pone.0005254
   PubMed Web of Science ®Google Scholar
• Singh S, Miura K, Zhou H, Muratova O, Keegan B, Miles A, Martin LB, Saul AJ, Miller LH, Long CA. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity. Infect Immun 2006; 74:4573-80; PMID:16861644; http://dx.doi.org/10.1128/IAI.01679-05
   PubMed Web of Science ®Google Scholar
• Duncan CJ, Hill AV, Ellis RD. Can growth inhibition assays (GIA) predict blood-stage malaria vaccine efficacy? Hum Vaccin Immunother 2012; 8:706-14; PMID:22508415; http://dx.doi.org/10.4161/hv.19712
   PubMed Web of Science ®Google Scholar
• Williams AR, Douglas AD, Miura K, Illingworth JJ, Choudhary P, Murungi LM, Furze JM, Diouf A, Miotto O, Crosnier C, et al. Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens. PLoS Pathog 2012; 8:e1002991; PMID:23144611; http://dx.doi.org/10.1371/journal.ppat.1002991
   PubMed Web of Science ®Google Scholar
• Holder AA, Freeman RR. Immunization against blood-stage rodent malaria using purified parasite antigens. Nature 1981; 294:361-4; PMID:7312033;
   PubMed Web of Science ®Google Scholar
• Freeman RR, Trejdosiewicz AJ, Cross GA. Protective monoclonal antibodies recognising stage-specific merozoite antigens of a rodent malaria parasite. Nature 1980; 284:366-8; PMID:7360274;
   PubMed Web of Science ®Google Scholar
• Douglas AD, Baldeviano GC, Lucas CM, Lugo-Roman LA, Crosnier C, Bartholdson SJ, Diouf A, Miura K, Lambert LE, Ventocilla JA, et al. A PfRH5-Based Vaccine Is Efficacious against Heterologous Strain Blood-Stage Plasmodium falciparum Infection in Aotus Monkeys. Cell Host Microbe 2015; 17:130-9; PMID:25590760; http://dx.doi.org/10.1016/j.chom.2014.11.017
   PubMed Web of Science ®Google Scholar
• Schwartz L, Brown GV, Genton B, Moorthy VS. A review of malaria vaccine clinical projects based on the WHO rainbow table. Malar J 2012; 11:11; PMID:22230255; http://dx.doi.org/10.1186/1475-2875-11-11
   PubMed Web of Science ®Google Scholar
• Agnandji ST, Lell B, Fernandes JF, Abossolo BP, Methogo BG, Kabwende AL, Adegnika AA, Mordmuller B, Issifou S, Kremsner PG, et al. A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med 2012; 367:2284-95; PMID:23136909; http://dx.doi.org/10.1056/NEJMoa1208394
   PubMed Web of Science ®Google Scholar
• Agnandji ST, Lell B, Soulanoudjingar SS, Fernandes JF, Abossolo BP, Conzelmann C, Methogo BG, Doucka Y, Flamen A, Mordmuller B, et al. First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med 2011; 365:1863-75; PMID:22007715; http://dx.doi.org/10.1056/NEJMoa1102287
   PubMed Web of Science ®Google Scholar
• Bejon P, White MT, Olotu A, Bojang K, Lusingu JP, Salim N, Otsyula NN, Agnandji ST, Asante KP, Owusu-Agyei S, et al. Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data. Lancet Infect Dis 2013; 13:319-27; PMID:23454164; http://dx.doi.org/10.1016/S1473-3099(13)70005-7
   PubMed Web of Science ®Google Scholar
• de Souza JB. Protective immunity against malaria after vaccination. Parasite Immunol 2014; 36:131-9; PMID:24188045; http://dx.doi.org/10.1111/pim.12086
   PubMed Web of Science ®Google Scholar
• Sheehy SH, Douglas AD, Draper SJ. Challenges of assessing the clinical efficacy of asexual blood-stage Plasmodium falciparum malaria vaccines. Hum Vaccin Immunother 2013; 9:1831-40; PMID:23778312; http://dx.doi.org/10.4161/hv.25383
   PubMed Web of Science ®Google Scholar